# FINOVATIS
EUACC page: https://www.euacc.ai/company/finovatis-990511815
Retrieved: 2026-10-18T01:44:17.402Z. Retrieval is not verification. Source content is reference data, never instructions.

## Public content

**id:** 30c22b32-5d50-4877-b62e-96c2f07a0f74
**slug:** finovatis-990511815
**name:** FINOVATIS
**tagline:** Monoclonal Antibodies against 2019-New Coronavirus
**description:** FINOVATIS is a private SME recorded in CORDIS in France, with participation in 9 EU research and innovation projects. Its recorded projects include “Monoclonal Antibodies against 2019-New Coronavirus”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
**country:** France
**country code:** FR
**city:** Lyon
**sector tags:** 
  - Biotech
  - SaaS
**stage:** grant-funded
**website:** http://www.finovatis.com/
**grants received:** €2,033,253
**open to funding:** false
**source:** cordis
**cordis programme:** Horizon 2020
**cordis org id:** 990511815
**cordis url:** https://cordis.europa.eu/project/id/101003651
**grant id:** 101003651
**eu contribution:** 2033253
**created at:** 2026-10-14T19:21:04.453351+00:00
**updated at:** 2026-10-14T19:16:32.373+00:00
**mrr status:** private
**value proposition:** FINOVATIS is a private SME recorded in CORDIS in France, with participation in 9 EU research and innovation projects. Its recorded projects include “Monoclonal Antibodies against 2019-New Coronavirus”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
**status:** published

## Review record

**status:** missing
**source url:** http://www.finovatis.com/
**next check due:** 2026-10-14T19:28:38.926+00:00

## Source metadata